TRACON Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancerhttps://www.high-endrolex.com/15, Our lead product candidate, envafolimab, is a PD-L1 antibody that is being developed for the treatment of sarcoma.